CUDC-101 is a potential target inhibitor for the EGFR-overexpression bladder cancer cells

Bladder cancer is one of the most common urological malignancies worldwide. The molecular mechanism underlying its development is complex, but its carcinogenesis has been proposed to occur with cell proliferation and resistance to apoptosis, driven by the signaling activity of abundant EGFR and rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenxing, Li, Lanxin, Chu, Chunhong, Wei, Xiangkai, Liu, Qian, Wang, Rui, Zhang, Guoliang, Wu, Guangyao, Wang, Ying, An, Lei, Li, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622178/
https://www.ncbi.nlm.nih.gov/pubmed/37830158
http://dx.doi.org/10.3892/ijo.2023.5579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622178/
https://www.ncbi.nlm.nih.gov/pubmed/37830158
http://dx.doi.org/10.3892/ijo.2023.5579

Ejemplares similares